109 related articles for article (PubMed ID: 25815488)
1. [Significance of trace deposition of immunoglobulin M in glomerular mesangium in children with minimal change nephrotic syndrome].
Li ZH; Xia TH; Duan CR; Wu TH; Xun M; Yin Y; Ding YF; Zhang Y; Zhang L
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Mar; 17(3):222-6. PubMed ID: 25815488
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
[TBL] [Abstract][Full Text] [Related]
3. Incidence & significance of IgM mesangial deposits in relapsing idiopathic nephrotic syndrome of childhood.
Bhuyan UN; Srivastava RN
Indian J Med Res; 1987 Jul; 86():53-60. PubMed ID: 3692560
[No Abstract] [Full Text] [Related]
4. Mesangial IgG in childhood minimal change disease: clinical relevance.
Abu-Farsakh H; Berry PL; Hill LL; Powell D; Hawkins EP
Clin Nephrol; 1993 May; 39(5):245-9. PubMed ID: 8513599
[TBL] [Abstract][Full Text] [Related]
5. Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.
Swartz SJ; Eldin KW; Hicks MJ; Feig DI
Pediatr Nephrol; 2009 Jun; 24(6):1187-92. PubMed ID: 19219463
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.
Hsu HC; Chen WY; Lin GJ; Chen L; Kao SL; Huang CC; Lin CY
Histopathology; 1984 May; 8(3):435-46. PubMed ID: 6376323
[TBL] [Abstract][Full Text] [Related]
7. Significance of mesangial IgA deposition in minimal change nephrotic syndrome: a study of 60 cases.
Choi J; Jeong HJ; Lee HY; Kim PK; Lee JS; Han DS
Yonsei Med J; 1990 Sep; 31(3):258-63. PubMed ID: 2281685
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
Maruyama M; Toyoda M; Umezono T; Miyauchi M; Yamamoto N; Kimura M; Honma M; Nishina M; Endoh M; Sakai H; Suzuki D
Nihon Jinzo Gakkai Shi; 2006; 48(1):14-21. PubMed ID: 16480062
[TBL] [Abstract][Full Text] [Related]
9. [Minimal change nephrotic syndrome with predominant mesangial IgA deposits: clinicopathological study].
Soma J; Saito T; Sato H; Ootaka T; Suzuki M; Chiba S; Taguma Y; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):153-9. PubMed ID: 2051642
[TBL] [Abstract][Full Text] [Related]
10. Childhood IgM nephropathy: comparison with minimal change disease.
Al-Eisa A; Carter JE; Lirenman DS; Magil AB
Nephron; 1996; 72(1):37-43. PubMed ID: 8903859
[TBL] [Abstract][Full Text] [Related]
11. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
12. Mesangial IGM in minimal change glomerular disease: a clinicopathological study in a Malaysian population.
Looi LM; Wang F; Lam KL; Chua CT
Pathology; 1985 Jan; 17(1):41-4. PubMed ID: 3889788
[TBL] [Abstract][Full Text] [Related]
13. IgM mesangial deposition as a risk factor for relapses of adult-onset minimal change disease.
Yang CW; Chen FY; Chang FP; Ho Y; Wu BS; Yang AH; Tarng DC; Yang CY
BMC Nephrol; 2021 Jan; 22(1):25. PubMed ID: 33435901
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
[TBL] [Abstract][Full Text] [Related]
15. The impact of IgM deposits on the outcome of Nephrotic syndrome in children.
Juozapaite S; Cerkauskiene R; Laurinavicius A; Jankauskiene A
BMC Nephrol; 2017 Aug; 18(1):260. PubMed ID: 28774288
[TBL] [Abstract][Full Text] [Related]
16. Is cyclophosphamide effective in patients with IgM-positive minimal change disease?
Geier P; Roushdi A; Skálová S; Vethamuthu J; Weiler G; Feber J
Pediatr Nephrol; 2012 Dec; 27(12):2227-31. PubMed ID: 22729760
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
Novak I; Frank R; Vento S; Vergara M; Gauthier B; Trachtman H
Pediatr Nephrol; 2005 Sep; 20(9):1265-8. PubMed ID: 15942779
[TBL] [Abstract][Full Text] [Related]
18. Significance of mesangial IgM deposition in "minimal change" nephrotic syndrome.
Vilches AR; Turner DR; Cameron JS; Ogg CS; Chantler C; Williams DG
Lab Invest; 1982 Jan; 46(1):10-5. PubMed ID: 7054586
[TBL] [Abstract][Full Text] [Related]
19. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
Yang T; Nast CC; Vo A; Jordan SC
Nephrol Dial Transplant; 2008 Jan; 23(1):377-80. PubMed ID: 17981884
[No Abstract] [Full Text] [Related]
20. [Effect of glucocorticoid on glucocorticoid-resistant children with primary nephrotic syndrome].
He XJ; Yi ZW; Dang XQ; Zhang HQ; He QN; Mo SH; Bai HT; Geng WM; Yang HB
Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):109-12. PubMed ID: 15833166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
